Posts in category: Uncategorized

A new research study published in JMIR Diabetes evaluated the real-world effectiveness of the Fitterfly Diabetes CGM digital therapeutic program for the management of glycemic control and weight in people with type 2 diabetes mellitus. The study led by Shilpa Joshi, Arbinder Singal, and colleagues found significant improvements in both blood glucose levels and weight management in participants enrolled in the 90-day program.

A new University of California San Diego School of Medicine study spotlights the significant reach that an individual health care cyberattack, such as ransomware, can have on regional hospital operations and patient care.

If you’re a health care provider treating people with type 2 diabetes (T2D), University at Buffalo researcher Mehmet A. Eskan has this suggestion for you: check your patients’ teeth.

A new research paper was published in Oncotarget, titled, “Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma.”

A decline in New York’s childbirth rate is showing no sign of reversing and many women are waiting longer to have children, according to newly compiled data from the Program in Applied Demographics (PAD) in the Cornell Jeb E. Brooks School of Public Policy.

Depression due to psychological stress affects millions of people worldwide. However, most of the existing anti-depressant drugs are slow, prone to development of resistance, and have severe side effects, demanding the need for more effective treatment options.

Globally, air pollution is a major public health hazard. A key air pollutant linked to health risks is ambient fine particulate matter (PM2.5), which consists of minute particles, sized less than or equal to 2.5 μm, suspended in the air.

Applying the same solution to different problems is a common mistake, not only among humans but also in our immune system. Flooding a wound with inflammation-causing white blood cells can be helpful for fighting infection, but when the immune system tries to apply this “solution” to a different purpose—fighting cancer—it can end up aiding tumor growth.

Researchers from the Innate Immunity group at the Germans Trias i Pujol Research Institute (IGTP) have developed a new immunotherapy based on a monoclonal antibody directed against tumor macrophages. The results obtained lay the foundations for a new treatment for patients with lung cancer, with the potential to be applied to other solid tumors. The study has been published in the journal eBioMedicine.

In early April 2023, Kenyan police discovered a mass grave linked to a Pentecostal church in the coastal town of Malindi. By the end of the month, at least 110 bodies had been dug up from shallow graves in the area’s Shakahola forest.